218 related articles for article (PubMed ID: 2142430)
1. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy.
Liebson PR
Am J Hypertens; 1990 Jun; 3(6 Pt 1):512-7. PubMed ID: 2142430
[TBL] [Abstract][Full Text] [Related]
2. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
3. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
[TBL] [Abstract][Full Text] [Related]
4. Regression of increased left ventricular mass by antihypertensives.
Lavie CJ; Ventura HO; Messerli FH
Drugs; 1991 Dec; 42(6):945-61. PubMed ID: 1724641
[TBL] [Abstract][Full Text] [Related]
5. [Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Sau F; Seguro C; Pili G; Basciu M; Siddi PP; Tamponi R; Cherchi A
Cardiologia; 1990 Dec; 35(12):1015-22. PubMed ID: 2151370
[TBL] [Abstract][Full Text] [Related]
6. ECG-gated cardiac scan and echocardiographic assessments of left ventricular hypertrophy: reversal by 6-month treatment with diltiazem.
Senda Y; Tohkai H; Kimura M; Shida Y; Tutumi S; Koshiyama H; Tanaka T; Shimaji Y; Nogita T
J Cardiovasc Pharmacol; 1990 Aug; 16(2):298-304. PubMed ID: 1697387
[TBL] [Abstract][Full Text] [Related]
7. Validity of the ECG diagnosis of left ventricular hypertrophy in normotensive and moderately hypertensive men when using the echocardiographic assessment of left ventricular mass index as reference.
Otterstad JE; Froeland G; Wasenius AK; Knutsen KM; Michelsen S; Stugaard M
J Hum Hypertens; 1991 Apr; 5(2):101-6. PubMed ID: 1830106
[TBL] [Abstract][Full Text] [Related]
8. Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.
Izzo R; Losi MA; Stabile E; Lönnebakken MT; Canciello G; Esposito G; Barbato E; De Luca N; Trimarco B; de Simone G
Hypertension; 2017 Jan; 69(1):136-142. PubMed ID: 27895192
[TBL] [Abstract][Full Text] [Related]
9. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
Okin PM; Devereux RB; Liu JE; Oikarinen L; Jern S; Kjeldsen SE; Julius S; Wachtell K; Nieminen MS; Dahlöf B
J Hum Hypertens; 2004 Jun; 18(6):403-9. PubMed ID: 15057252
[TBL] [Abstract][Full Text] [Related]
10. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
Pierdomenico SD; Lapenna D; Cuccurullo F
Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
[TBL] [Abstract][Full Text] [Related]
11. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
Ketelhut S; Franz IW; Ketelhut RG
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
[TBL] [Abstract][Full Text] [Related]
12. [Regression of left ventricular hypertrophy with antihypertensive treatment].
Galinier M; Bounhoure JP
Presse Med; 1990 Nov; 19(37):1715-9. PubMed ID: 1979167
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
Strauer BE
Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial.
MacMahon S; Collins G; Rautaharju P; Cutler J; Neaton J; Prineas R; Crow R; Stamler J
Am J Cardiol; 1989 Jan; 63(3):202-10. PubMed ID: 2521269
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular hypertrophy: dissociation of structural and functional effects by therapy.
Frohlich ED
Adv Exp Med Biol; 1991; 308():175-90. PubMed ID: 1839347
[TBL] [Abstract][Full Text] [Related]
16. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
[TBL] [Abstract][Full Text] [Related]
17. Effects of antihypertensive agents on the left ventricle: clinical implications.
Díez J; González A; López B; Ravassa S; Fortuño MA
Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
[TBL] [Abstract][Full Text] [Related]
18. Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death.
Messerli FH; Soria F
Am J Med; 1992 Aug; 93(2A):21S-26S. PubMed ID: 1387763
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
20. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
Okin PM; Wachtell K; Gerdts E; Dahlöf B; Devereux RB
J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
